Seek revenue guidance for FY23 downgraded by 1.2% and shares fall by 5%
Nick Sundich, April 4, 2023
Barely 6 weeks after it was issued, Seek’s revenue guidance for FY23 was cut. This led to a 5% sell-off in shares this morning, but it is still in positive territory in FY23.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Seek revenue guidance cut from A$1.26bn to $1.245bn
Seek’s revenue guidance was only cut by 1.2%, from $1.26bn to $1.245bn. Shares in the company fell by 5% this morning. Despite today’s losses, shares are still up on a YTD basis.
An over-reaction?
You could argue this was an over-reaction given that its EBITDA and NPAT guidance was unchanged and reiterated. However, three things may be of concern to investors.
First, it gave a warning that job ad volumes were moderating. The company wasn’t specific beyond that general warning – it did not state the extent to which they were moderating and how long it was expected. Granted, it is clearly not too vehement if Seek’s revenue guidance is only being downgraded by 1%.
Second, the company’s unchanged EBITDA and NPAT guidance was assumed to be offset by lower than assumed operating expenditure. And third, the fact that the company’s guidance was downgraded so soon after it was iterated.
Ultimately, only time will tell if its guidance holds. But investors may be forgiven for being sceptical amidst 4-decade high inflation.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
These 2 key milestones awaiting Recce Pharmaceuticals could be very exciting and value accretive!
There are 2 key milestones awaiting Recce Pharmaceuticals (ASX:RCE) in the next few months that investors in this company need…
Here are the 30 best investing quotes for stock investors
What are the best investing quotes? Warren Buffett would account for several such as ‘be fearful when others are greedy’ and…
Xmas is Always Good for Endeavour Drinks (ASX: EDV), but How is EDV Doing in the Longer Term?
With soaring spirits during the holiday season, Endeavour Group Limited, one of Australia’s largest retailers of alcoholic beverages, experiences a…